MedPath

Fluoroscopic Guided vs US-guided Percutaneous Nephrolithotripsy for the Treatment of Stone Disease

Not Applicable
Conditions
Urolithiasis
Kidney Stone
Kidney Calculi
Ureteral Calculi
Kidney Diseases
Interventions
Procedure: PCNL under fluoroscopic control
Procedure: PCNL under ultrasound control
Registration Number
NCT04606758
Lead Sponsor
Astana Medical University
Brief Summary

Randomized comparison of patient outcomes following fluoroscopic guided PCNL versus ultrasound-guided PCNL.

Detailed Description

This study is a randomized controlled trial that compares the operative outcomes and complications of fluoroscopic guided-percutaneous nephrolithotomy versus ultrasound-guided PCNL for renal stones. This study will be a prospective randomized controlled clinical trial with patients who have already agreed to undergo PCNL. Patients will be randomized at a 1:1 ratio to receive either PCNL under fluoroscopic guidance or PCNL under ultrasound guidance. Patients will be asked to complete pre-operative, and postoperative quality of life questionnaires, and to allow the collection of one additional vial of blood for measurement of factors associated with inflammation.

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
150
Inclusion Criteria
  • Patients planned for PCNL at participating institution
  • Patients of all ethnic backgrounds
  • Stone size over 10 mm in diameter and a density over 900 Hounsfield units
  • Patients with a large calculus in the upper third of the ureter
Exclusion Criteria
  • Pregnancy
  • infectious disease of the genitals;
  • conditions that violate the configuration of the kidneys (curvature of the spinal column)
  • anomalies in the development of the kidneys with impaired configuration and position of the kidneys (horseshoe kidney, bisque kidney, S-shaped kidney, L-shaped kidney, lumbar dystopia, iliac dystopia, pelvic dystopia)
  • presence of nephrostomy drainage in the target kidney;
  • urethral stricture or other reason leading to the inability to carry out ureteral catheterization;
  • other conditions that are contraindications to surgical treatment, such as uncontrolled diabetes mellitus, acute cardiovascular conditions, liver failure, alcoholism, and drug addiction;
  • patients who are unable to understand the purpose of the study or refuse further follow-up observation and instructions after treatment;
  • patients with a history of mental illness;
  • participation in another research that interferes with this research;
  • acute renal failure;
  • dissecting aortic aneurysm;
  • acute hypertensive encephalopathy;
  • heavy arterial bleeding;
  • myocardial infarction less than six months before enrollment in the study;
  • Stroke less than six months before enrollment in the study;
  • Insufficiency of blood circulation III-IV New York Heart Association class;
  • Severe rhythm and conduction disturbances;
  • Increase in the level of liver transaminases by more than three times;

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
PCNL under fluoroscopic controlPCNL under fluoroscopic control-
PCNL under ultrasound controlPCNL under ultrasound control-
Primary Outcome Measures
NameTimeMethod
Blood loss as estimated by postoperative decreases in haemoglobinPost-operative day 1
Secondary Outcome Measures
NameTimeMethod
Surgical outcomes6 months

Outcome measures by using the clavien dindo classification system

Asses the easiness of accessibility of the targeted stoneIntraoperatively

Outcome measures by counting numbers of puncture trial

The Puncture fluoroscopy screening timeIntraoperatively

assessed on the monitor of C-Arm.

© Copyright 2025. All Rights Reserved by MedPath